The lesson teaches the following:
Diabetes, Diabetes, Pharmaceutical Therapies for Managing Hyperglycemia, Pancreatic Hormones
Diabetes, Diabetes, Pharmaceutical Therapies for Managing Hyperglycemia, Pancreatic Hormones, Insulin
Diabetes, Diabetes, Pharmaceutical Therapies for Managing Hyperglycemia, Pancreatic Hormones, Amylin
Diabetes, Diabetes, Pharmaceutical Therapies for Managing Hyperglycemia, Secretagogues
Diabetes, Diabetes, Pharmaceutical Therapies for Managing Hyperglycemia, Secretagogues, Sulfonylurea, Insulin
Diabetes, Diabetes, Pharmaceutical Therapies for Managing Hyperglycemia, Secretagogues, Incretins
Diabetes, Diabetes, Pharmaceutical Therapies for Managing Hyperglycemia, Overview
Diabetes, Diabetes, Pharmaceutical Therapies for Managing Hyperglycemia, α-Glucosidase Inhibitors
Diabetes, Diabetes, Pharmaceutical Therapies for Managing Hyperglycemia, Insulin Sensitizers, Thiazolidinediones
Diabetes, Diabetes, Pharmaceutical Therapies for Managing Hyperglycemia, Insulin Sensitizers
Diabetes, Diabetes, Pharmaceutical Therapies for Managing Hyperglycemia, Insulin Sensitizers, Metformin
Insulin and amylin are cosecreted from beta cells of the endocrine pancreas.
Amylin:
Secretagogues enhance insulin secretion by the pancreas.
Type 2 diabetes is a disease of insulin resistance in liver and peripheral tissues and declining insulin production by beta cells of the pancreas.
α-glucosidase inhibitors act in the intestines to delay the breakdown and absorption of dietary carbohydrates after a meal.
Insulin sensitizers act at the tissues that respond to insulin.
Metformin improves insulin sensitivity in liver and muscle.
TZDs - Thiazolidinediones (Glitazones)